Back to today’s briefing

Story perspectives

UCLA Study Questions Medical Cannabis Efficacy, Abuse Risks

12/15/2025

50 9 Full Breakdown

Summary

Story summary

A JAMA analysis by UCLA Health challenges the efficacy of medical cannabis for acute pain and insomnia.
The study reviews 15 years of data.
The study finds nearly one-third of medical cannabis users show signs of abuse.
FDA-approved cannabinoids help with chemotherapy-induced nausea and HIV-related weight loss.
High-potency cannabis is linked to increased psychosis risk.

1 of 1

Story summary

A JAMA analysis by UCLA Health challenges the efficacy of medical cannabis for acute pain and insomnia.
The study reviews 15 years of data.
The study finds nearly one-third of medical cannabis users show signs of abuse.
FDA-approved cannabinoids help with chemotherapy-induced nausea and HIV-related weight loss.
High-potency cannabis is linked to increased psychosis risk.